Study of Surufatinib Single Agent or Surufatinib Combined With Toripalimab in Patients With Advanced Solid Tumors
Clinical trial NCT04169672 · COMPLETED
Trial details
- NCT number
- NCT04169672
- Sponsor
- Hutchison Medipharma Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-26
- Primary completion
- 2023-02-28
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.